+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

The Market for Implanted Pain Neuromodulation Systems: 2021-2026

  • PDF Icon


  • 75 Pages
  • April 2021
  • Region: Global
  • Neurotech Reports
  • ID: 5638889

This newly published market research report examines the market for implantable pain neuromodulation devices in the years subsequent to the coronavirus pandemic. The report covers the events and developments that will impact the implanted pain neuromodulation system marketplace in the years 2021 through 2026. These include the impact of the pandemic, the segmentation of neuromodulation therapies, consolidation and M&A activity within the space, and the role played by an influx of new implanting clinicians in the years ahead.

The report offers authoritative market forecasts for revenues and growth rates of SCS and PNS systems, both worldwide and within the U.S. We also include our estimates of worldwide market share for both SCS and PNS systems, and we discuss potential new entrants in the

The editors conducted more than three dozen interviews with implanting physicians in 2020, after the onset of the pandemic. In addition, we conducted confidential interviews with executives and former executives of several publicly traded and privately held neuromodulation firms. This authoritative and timely report includes valuable market intelligence on the neuromodulation industry such as:

  • The segmentation and differentiation within the SCS and PNS industry
  • Comprehensive profiles of the key public and private competitors in the space
  • The key indications identified by implanters as best suited for SCS or PNS therapies
  • Reimbursement update for SCS and PNS systems
  • Likely new entrants in the pain neuromodulation space

Table of Contents

  • Executive Summary
  • Industry Outlook
  • Market Forecasts
  • SCS Therapies
  • PNS Therapies
  • Clinician Survey Results
  • Competitor Profiles
  • Recent Pain Conference Reports
List of Tables and Figures
  • Worldwide Market for Implanted Pain Neuromodulation Systems
  • U.S. Market for Implanted Pain Neuromodulation Systems
  • SCS Market Share, 2021
  • SCS Market Share, 2023
  • PNS Market Share, 2021
  • PNS Market Share, 2023
  • SCS Devices Implanted per Clinician per Year
  • PNS Devices Implanted per Clinician per Year
  • SCS Systems Implanted by Manufacturer
  • PNS Systems Implanted by Manufacturer
  • CMS Reimbursement for SCS and PNS Procedures
  • 510(k) Device Clearance for PNS Systems
  • Annual Implantation Volume of Clinicians
  • Several Others

Companies Mentioned

  • Medtronic
  • Abbott
  • Boston Scientific
  • Nevro
  • Saluda Medical
  • Mainstay Medical
  • SPR Therapeutics
  • Bioness/Bioventus
  • Nalu Medical
  • Stimwave
  • Neuros Medical